Structural models of how myosin moves actin and produces force hypothesize that the interface between the motor domains and the light-chain (LC) binding neck region is a pivot point for bending of the two domains relative to each other. Many point mutations implicated in familial hypertrophic cardiomyopathies (FHC) are clustered in the beta-myosin heavy chain at the essential LC (ELC) binding interface, as well as in the LCs themselves. The effect of heavy chain mutations found in FHC on myosin's enzymatic and mechanical properties (steady-state and transient kinetics, velocity, unitary force, and unitary step size) will be analyzed in the first aim. Heavy chain mutations will be engineered into smooth muscle myosin and expressed in the baculovirus/insect cell system, to determine which mutations are critical for the function of all myosins. A concurrent goal is to increase the yield of expressed cardiac HMM so that comparable experiments can be performed on expressed cardiac mutants. Cardiac myosin with a subset of these FHC mutations will also be isolated from transgenic mice (obtained from Core C), and analyzed similarly. Such comparative studies should contribute to understanding the basic mechanical properties of all myosins, as well as providing a molecular basis for the effect of selected FHC mutations.
The second aim focuses on how FHC mutations in the cardiac regulatory and essential LCs affect cardiac myosin's enzymatic and mechanical properties. Since atrial ELC accumulates in the ventricle in different forms of human ventricular hypertrophies, the kinetic and mechanical properties of a beta-cardiac myosin/atrial ELC chimera will also be determined. In both cases, bacterially expressed cardiac LCs will be reconstituted with LC-deficient beta-cardiac myosin heavy chain prepared from tissue, and assayed for functional properties by the techniques described for the first aim. The overall goal of the proposal is to elucidate how mutations implicated in FHC affect the mechanical performance of myosin.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL059408-01A1
Application #
6110904
Study Section
Project Start
1999-02-18
Project End
2000-01-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Singh, Sonia R; Robbins, Jeffrey (2018) Desmin and Cardiac Disease: An Unfolding Story. Circ Res 122:1324-1326
Lin, Brian Leei; Li, Amy; Mun, Ji Young et al. (2018) Skeletal myosin binding protein-C isoforms regulate thin filament activity in a Ca2+-dependent manner. Sci Rep 8:2604
Kensler, Robert W; Craig, Roger; Moss, Richard L (2017) Phosphorylation of cardiac myosin binding protein C releases myosin heads from the surface of cardiac thick filaments. Proc Natl Acad Sci U S A 114:E1355-E1364
McLendon, Patrick M; Davis, Gregory; Gulick, James et al. (2017) An Unbiased High-Throughput Screen to Identify Novel Effectors That Impact on Cardiomyocyte Aggregate Levels. Circ Res 121:604-616
Bhuiyan, Md Shenuarin; McLendon, Patrick; James, Jeanne et al. (2016) In vivo definition of cardiac myosin-binding protein C's critical interactions with myosin. Pflugers Arch 468:1685-95
Gupta, Manish K; McLendon, Patrick M; Gulick, James et al. (2016) UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts. Circ Res 118:1894-905
Warshaw, David M (2016) HEART DISEASE. Throttling back the heart's molecular motor. Science 351:556-7
James, Jeanne; Robbins, Jeffrey (2016) Healing a Heart Through Genetic Intervention. Circ Res 118:920-2
Mun, Ji Young; Kensler, Robert W; Harris, Samantha P et al. (2016) The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position. J Mol Cell Cardiol 91:141-7
Previs, Michael J; Mun, Ji Young; Michalek, Arthur J et al. (2016) Phosphorylation and calcium antagonistically tune myosin-binding protein C's structure and function. Proc Natl Acad Sci U S A 113:3239-44

Showing the most recent 10 out of 168 publications